Table 4 Relationship between CD117 and bio-pathological variables in 113 squamous cell carcinoma patients

From: CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients

Variable

Category

Membrane

P

Cytoplasmic

P

  

0–4.99%

5%

 

0–4.99%

5%

 

Age (year)

Median

63

64

NS

63

66

NS

Gender

Male

95 (97%)

14 (93%)

NS

101 (96%)

8 (100%)

NS

 

Female

3 (3%)

1 (7%)

 

4 (4%)

0

 

Symptoms at diagnosisa

Absent

27 (28%)

8 (53%)

NS

33 (32%)

2 (25%)

NS

 

Local

41 (43%)

5 (33%)

 

43 (42%)

3 (37%)

 
 

Systemic

27 (28%)

2 (13%)

 

26 (26%)

3 (37%)

 

Vascular invasion

Yes

71 (72%)

13 (87%)

NS

77 (73%)

7 (87%)

NS

 

No

27 (28%)

2 (13%)

 

28 (27%)

1 (13%)

 

pT

1

52 (53%)

5 (33%)

NS

53 (50%)

4 (50%)

NS

 

2

46 (47%)

10 (67%)

 

52 (49%)

4 (50%)

 

Tumor grade

1

1 (1%)

0

0.001

1 (1%)

0

0.03

 

2

71 (72%)

4 (27%)

 

73 (70%)

2 (25%)

 
 

3

26 (27%)

11 (73%)

 

31 (29%)

6 (75%)

 

Size (cm)

Median

3.0

4.0

NS

3.0

3.3

NS

Ki-67 (%)

Median

42

37

NS

42

32.5

NS

Synaptophysin

Neg

89 (91%)

12 (80%)

NS

94 (90%)

7 (87%)

NS

 

Pos

9 (9%)

3 (20%)

 

11 (10%)

1 (12%)

 

Chromogranin A

Neg

89 (91%)

14 (93%)

NS

95 (90%)

8 (100%)

NS

 

Pos

9 (9%)

1 (7%)

 

10 (9%)

0

 

Fascin

Neg

0

2 (13%)

0.009

1 (1%)

1 (12%)

NS

 

Pos

98 (100)

13 (87%)

 

104 (99%)

7 (87%)

 

Her-2

Neg

65 (66%)

7 (47%)

NS

67 (64%)

5 (62%)

NS

 

Pos

33 (34%)

8 (53%)

 

38 (34%)

3 (37%)

 

Bcl-2 (%)

Median

1.9

78.5

<0.001

3.0

3.3

NS

Cyclin-E (%)

Median

29.8

17.3

NS

2.2

30.5

0.007

p53 (%)

Median

6.0

24.0

NS

31.0

0

NS

p21Waf1(%)

Median

14.5

10.8

NS

14.3

11.5

NS

p27Kip1 (%)

Median

9.3

41.4

0.001

10.4

26.2

NS

Microvessel density

Median

90

108

0.04

92

94

NS

  1. aIn three patients the data on symptoms were not available.